AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Learn how personalized exercise routines can transform your COPD journey, enhance resilience, and improve your quality of ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...

Novo Nordisk's Ozempic and Wegovy are among 15 drugs targeted for Medicare price negotiations in 2027. The U.S. aims to cut ...